The serum IL-21 concentration was a positive trend of the correlation with the UPDRS-III score and H-Y stage in PD patients, which suggests that IL-21 may be a biomarker for monitoring the severity of PD and a possible target for disease intervention. Here, IL21 is linked to Parkinson disease.